CellWell record HH-539072
Factors Associated with PSA Doubling and PSA Doubling Time After Androgen Deprivation Therapy in Prostate Cancer Patients: A Multivariate Analysis
Ting Xie; Jiaxu Yan; Guodong Zhang; Lijie Liu; Tao Gu
2026
In plain language
In 140 retrospectively studied prostate cancer patients on androgen deprivation therapy, nadir PSA and monthly PSA decline velocity were independent risk factors for PSA doubling within 24 months, with nadir PSA predicting best.
- Evidence
- Emerging
- Design
- Preprint
Cite this record: https://thecellwell.org/studies/HH-539072
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.